Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-177093
Filing Date
2026-04-24
Accepted
2026-04-24 16:03:51
Documents
16

Document Format Files

Seq Description Document Type Size
1 S-3 d122209ds3.htm S-3 215699
2 EX-5.1 d122209dex51.htm EX-5.1 11099
3 EX-23.1 d122209dex231.htm EX-23.1 1779
4 EX-FILING FEES d122209dexfilingfees.htm   iXBRL EX-FILING FEES 18191
5 GRAPHIC g122209g00g03.jpg GRAPHIC 603438
6 GRAPHIC g122209snap1.jpg GRAPHIC 6399
7 GRAPHIC g122209snap2.jpg GRAPHIC 2939
  Complete submission text file 0001193125-26-177093.txt   1201926

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d122209dexfilingfees_htm.xml XML 5075
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-295304 | Film No.: 26893508
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)